Genetic aspects of the Paget's disease of bone: Concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application

European Journal of Clinical Investigation

Volumn 40, Issue 7, 2010, Pages 655-667

  Alberto, Falchetti ^a   Francesca, Marini ^a   Laura, Masi ^a   Antonietta, Amedei ^a   Luisa, Brandi Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

DNA based test; Genetics of Paget's disease of bone; Metabolic bone disorder; Paget's disease of bone; SQSTM1 p62

Indexed keywords

DNA; PROTEIN P62;

DIFFERENTIATION; DISEASE PREDISPOSITION; DNA DETERMINATION; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HEREDITY; HUMAN; OSTEOCLAST; PAGET BONE DISEASE; PENETRANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SQSTM1 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DNA; GENETIC TESTING; HUMANS; MUTATION; OSTEITIS DEFORMANS; RISK FACTORS;

EID: 77953516035     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02312.x     Document Type: Review

References (102)

1. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002 17: 465 471.
2. Poor G, Donáth J, Fornet B, Cooper C. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Miner Res 2006 21: 1545 1549.
3. Kanis JA. Pathophysiology and Treatment of Paget's Disease of Bone.
4. Seitz S, Priemel M, Zustin J, Beil FT, Semler J, Minne H et al. Paget's disease of bone: histologic analysis of 754 patients. J Bone Miner Res 2009 24: 62 9.
5. Osterberg PH, Wallace RG, Adams DA, Crone RS, Dickson GR, Kanis JA et al. Familial expansile osteolysis. A new dysplasia. J Bone Joint Surg Br 1988 70: 255 260.
6. Whyte MP, Mills BG, Reinus WR, Podgornik MN, Roodman GD, Gannon FH et al. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J Bone Miner Res 2000 15: 2330 2344.
7. Nakatsuka K, Nishizawa Y, Ralston SH. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 2003 18: 1381 1385.
8. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH et al. Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 2002 347: 175 184.
9. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 2001 74: 458 475.
10. Gennari L, Di Stefano M, Merlotti D, Giordano N, Martini G, Tamone C et al. Prevalence of Paget's Disease of Bone in Italy. J Bone Miner Res 2005 20: 1845 1850.
11. Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ 3rd. Morbidity and mortality associated with Paget's disease of bone: a population-based study. J Bone Miner Res 2008 23: 819 825.
12. Tiegs RD, Lohse CM, Wollan PC, Melton LJ. Long-term trends in the incidence of Paget's disease of bone. Bone 2000 27: 423 427.
13. Barker DJ, Gardner MJ. Distribution of Paget's disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood. Br J Prev Soc Med 1974 28: 226 232.
14. Gardner MJ, Barker DJ. Mortality from malignant tumours of bone and Paget's disease in the United States and in England and Wales. Int J Epidemiol 1978 7: 121 130.
15. Cundy T, McAnulty K, Wattie D, Gamble G, Rutland M, Ibbertson HK. Evidence for secular change in Paget's disease. Bone 1997 20: 69 71.
16. Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D. The epidemiology of Paget's disease in Britain: is the prevalence decreasing? J Bone Miner Res 1999 14: 192 197.
17. Seton M, Choi HK, Hansen MF, Sebaldt RJ, Cooper C. Analysis of environmental factors in familial versus sporadic Paget's disease of bone-the New England Registry for Paget's Disease of Bone. J Bone Miner Res 2003 18: 1519 1524.
18. Jacobs TP, Michelsen J, Polay JS, D'Adamo AC, Canfield RE. Giant cell tumor in Paget's disease of bone: familial and geographic clustering. Cancer 1979 44: 742 747.
19. Rendina D, Gennari L, De Filippo G, Merlotti D, de Campora E, Fazioli F et al. Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res 2006 21: 1828 1835.
20. Singer FR, Mills BG. Giant cell tumor arising in Paget's disease of bone. Recurrences after 36 years. Clin Orthop Relat Res 1993 293: 293 301.
21. Johnson-Pais TL, Wisdom JH, Weldon KS, Cody JD, Hansen MF, Singer FR et al. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res 2003 18: 1748 1753.
22. Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP et al. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res 2004 19: 1122 1127.
23. Gennari L, Gianfrancesco F, Di Stefano M, Rendina D, Merlotti D, Esposito T et al. SQSTM1 gene analysis and gene-environment interaction in paget's disease of bone. J Bone Miner Res 2010 Epub ahead of print.
24. Rebel A, Malkani K, Basle M. Nuclear anomalies in osteoclasts in Paget's bone disease. Nouv Presse Med 1974 3: 1299 1301.
25. Mills BG, Singer FR. Nuclear inclusions in Paget's disease of bone. Science 1976 194: 201 202.
26. Merchant A, Smielewska M, Patel N, Akunowicz JD, Saria EA, Delaney JD et al. Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget disease of bone. J Bone Miner Res 2009 24: 484 494.
27. Rebel A, Basle M, Pouplard A, Malkani K, Filmon R, Lepatezour A. Bone tissue in Paget's disease of bone-Ultrastructure and immunocytology. Arthritis Rheum 1980 23: 1104 1114. (Pubitemid 10021685)
28. Reddy SV, Singer FR, Roodman GD. Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 1995 80: 2108 2111.
29. Friedrichs WE, Reddy SV, Bruder JM, Cundy T, Cornish J, Singer FR et al. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 2002 17: 145 151.
30. Mee AP, Dixon JA, Hoyland JA, Davies M, Selby PL, Mawer EB. Detection of canine distemper virus in 100% of Paget's disease samples by in situ reverse transcriptase-polymerase chain reaction. Bone 1998 23: 171 175.
31. Mills BG, Frausto A, Singer FR, Ohsaki Y, Demulder A, Roodman GD. Multinucleated cells formed in-vitro from Pagets bone-marrow express viral antigens. Bone 1994 15: 443 448.
32. Helfrich MH, Hobson RP, Grabowski PS, Zurbriggen A, Cosby SL, Dickson GR et al. A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res 2000 15: 2315 2329.
33. Ooi CG, Walsh CA, Gallagher JA, Fraser WD. Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 2000 27: 417 421.
34. Ralston SH, Afzal MA, Helfrich MH, Fraser WD, Gallagher JA, Mee A et al. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J Bone Miner Res 2007 22: 569 577.
35. Matthews BG, Afzal MA, Minor PD, Bava U, Callon KE, Pitto RP et al. Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease. J Clin Endocrinol Metab 2008 93: 1398 1401.
36. Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest 2000 105: 607 614.
37. Reddy SV, Kurihara N, Menaa C, Landucci G, Forthal D, Koop BA et al. Osteoclasts formed by measles virus infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts. Endocrinology 2001 142: 2898 2905.
38. Selby PL, Davies M, Mee AP. Canine distemper virus induces human osteoclastogenesis through NF-kappa B and sequestosome 1/p62 activation. J Bone Miner Res 2006 21: 1750 1756.
39. Kurihara N, Zhou H, Reddy SV, Garcia Palacios V, Subler MA, Dempster DW et al. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res 2006 21: 446 455.
40. Barker DJP. The epidemiology of Paget's disease of bone. Br Med Bull 1984 40: 396 400.
41. Detheridge FM, Guyer PB, Barker DJP. European distribution of Paget's disease of bone. Br Med J 1982 285: 1005 1008.
42. Barker DJP, Chamberlain AT, Guyer PB, Gardner MJ. Paget disease of bone-the Lancashire focus. Br Med J 1980 280: 1105 1107.
43. Guañabens N, Garrido J, Gobbo M, Piga AM, del Pino J, Torrijos A et al. Prevalence of Paget's disease of bone in Spain. Bone 2008 43: 1006 1009.
44. Merlotti D, Gennari L, Galli B, Martini G, Calabrò A, De Paola V et al. Characteristics and familial aggregation of Paget's disease of Bone in Italy. J Bone Miner Res 2005 20: 1356 1364.
45. Falchetti A, Di Stefano M, Marini F, Ortolani S, Ulivieri MF, Bergui S et al. Genetic epidemiology of Paget's disease of bone in Italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone. Calcif Tissue Int 2009 84: 20 37.
46. Gardner MJ, Guyer PB, Barker DJP. Paget's disease of bone among British migrants to Australia. Br Med J 1978 2: 1436 1437.
47. Reasbeck JC, Goulding A, Campbell DR, Beale LR, Stewart RDH. Radiological prevalence of Paget's disease in Dunedin, New Zealand. Br Med J 1983 286: 1937.
48. Gomez Acotto C, Mautalen CA. European origin of patients with Paget's disease of bone in the Buenos Aires area. Eur J Epidemiol 2001 17: 409 411.
49. Griz L, Caldas G, Bandeira C, Assuncao V, Bandeira F. Paget's disease of bone. Arq Bras Endocrinol Metabol 2006 50: 814 822.
50. Montagu MFA. Paget's disease (osteitis deformans) and hereditary. Am J Hum Genet 1949 1: 94 5.
51. Langston AL, Campbell MK, Fraser WD, Maclennan G, Selby P, Ralston SH. Clinical determinants of quality of life in Paget's disease of bone. Calcif Tissue Int 2007 80: 1 9.
52. Siris ES, Ottman R, Flaster E, Kelsey JL. Familial aggregation of Paget's disease of bone. J Bone Miner Res 1991 6: 495 500.
53. Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 2002 70: 1582 1588.
54. Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 2002 11: 2735 2739.
55. Morissette J, Laurin N, Brown JP. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J Bone Miner Res 2007 21: P38 44.
56. Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP et al. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent. J Bone Miner Res 2005 20: 227 231.
57. Bolland MJ, Tong PC, Naot D, Callon KE, Wattie DJ, Gamble GD et al. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 2007 22: 411 415.
58. Geetha T, Wooten MW. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 2002 512: 19 24.
59. Paine MG, Babu JR, Seibenhener ML, Wooten MW. Evidence for p62 aggregate formation: role in cell survival. FEBS Lett 2005 579: 5029 5034.
60. Bjørkøy G, Lamark T, Johansen T. p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2006 2: 138 139.
61. Rodriguez A, Durán A, Selloum M, Champy MF, Diez-Guerra FJ, Flores JM et al. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab 2006 3: 211 222.
62. Goode A, Layfield R. Recent advances in understanding the molecular basis of Paget disease of bone. J Clin Pathol 2010 63: 199 203.
63. Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 2004 6: 303 309.
64. Rea SL, Walsh JP, Ward L, Yip K, Ward BK, Kent GN et al. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype. J Bone Miner Res 2006 21: 1136 1145.
65. Yip KH, Feng H, Pavlos NJ, Zheng MH, Xu J. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone. Am J Pathol 2006 169: 503 514.
66. Najat D, Garner T, Hagen T, Shaw B, Sheppard PW, Falchetti A et al. Characterisation of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone. J Bone Miner Res 2009 24: 632 642.
67. Rea SL, Walsh J, Ward L, Magno A, Ward B, Shaw B et al. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation and a novel non-UBA domain mutation (P364S) associated with increased NFκB signaling without loss of ubiquitin-binding. J Bone Miner Res 2009 24: 1216 1223.
68. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007 282: 24131 24145.
69. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007 131: 1149 1163.
70. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008 451: 1069 1075.
71. Nakamura K, Kimple AJ, Siderovski DP, Johnson GL. PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem 2010 3: 2077 2089.
72. Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I et al. The IKK complex contributes to the induction of autophagy. EMBO J 2010 29: 619 631.
73. Layfield R. The molecular pathogenesis of Paget disease of bone. Expert Rev Mol Med 2007 9: 1 13.
74. Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR et al. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest 2007 117: 133 142.
75. Ciani B, Layfield R, Cavey JR, Sheppard PW, Searle MS. Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J Biol Chem 2003 278: 37409 37412.
76. Long J, Gallagher TR, Cavey JR, Sheppard PW, Ralston SH, Layfield R et al. Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. J Biol Chem 2008 283: 5427 5440.
77. Layfield R, Searle MS. Disruption of ubiquitin-mediated processes in diseases of the brain and bone. Biochem Soc Trans 2008 36: 469 471.
78. Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B, Searle MS et al. Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J Bone Miner Res 2005 20: 619 624.
79. Cavey JR, Ralston SH, Sheppard PW, Ciani B, Gallagher TR, Long JE et al. Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone. Calcif Tissue Int 2006 78: 271 277.
80. Collet C, Michou L, Audran M, Chasseigneaux S, Hilliquin P, Bardin T et al. Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J Bone Miner Res 2007 22: 310 317.
81. Langston AL, Johnston M, Robertson C, Campbell MK, Entwistle VA, Marteau TM et al. Protocol for stage 1 of the GaP study (genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available? BMC Health Serv Res 2006 6: 71.
82. Langston AL, Johnston M, Francis J, Robertson C, Campbell MK, Entwistle VA et al. Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available. BMC Health Serv Res 2008 8: 116.
83. Shoji-Kawata S, Levine B. Autophagy, antiviral immunity, and viral countermeasures. Biochim Biophys Acta 2009 1793: 1478 1484.
84. Matthews BG, Naot D, Bava U, Callon KE, Pitto RP, McCowan SA et al. Absence of somatic SQSTM1 mutations in Paget's disease of bone. J Clin Endocrinol Metab 2009 94: 691 694.
85. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001 86: 5658 5671.
86. Good DA, Busfield F, Fletcher BH, Lovelock PK, Duffy DL, Kesting JB et al. Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 2004 35: 277 282.
87. Eekhoff EW, Karperien M, Houtsma D, Zwinderman AH, Dragoiescu C, Kneppers AL et al. Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 2004 50: 1650 1654.
88. Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F et al. Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 2001 28: 104 107.
89. Daroszewska A, Hocking LJ, McGuigan FE, Langdahl B, Stone MD, Cundy T et al. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. J Bone Miner Res 2004 19: 1506 1511.
90. Beyens G, Daroszewska A, de Freitas F, Fransen E, Vanhoenacker F, Verbruggen L et al. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J Bone Miner Res 2007 22: 1062 1071.
91. Turtzo LC, McCullough LD. Sex-specific responses to stroke. Future Neurol 2010 5: 47 59.
92. Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M et al. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry 2007 62: 536 540.
93. Lang UE, Bajbouj M, Sander T, Gallinat J. Gender dependent association of the functional catechol-Omethyltransferase Val158Met genotype with sensation seeking personality trait. Neuropsychopharmacology 2007 32: 1950 1955.
94. Donath J, Speer G, Poo′r G, Gergely P Jr., Taba′k A, Lakatos P. Vitamin D receptor, oestrogen receptor-alpha and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone. Rheumatology (Oxford) 2004 43: 692 695.
95. Brandi ML, Falchetti A. What is the relationship between Paget's disease of bone and hyperparathyroidism? J Bone Miner Res 2006 21 (Suppl. 2 P69 74.
96. Gray JR, Soldan JR, Harper PS. Special problems of genetic counseling in adult-onset diseases: Huntington's disease as a model. In: Baker HF, Ridley RM, editors. Prion Diseases (Series: Methods in Molecular Medicine)
97. Evers-Kiebooms G, Welkenhuysen M, Claes E, Decruyenaere M, Denayer L. The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. Soc Sci Med 2000 51: 831 841.
98. Varga O, Sequeiros J. Definitions of genetic testing in European and other legal documents. EuroGentest Unit 3 (WP3.4), 2009. Available at: http://www.eurogentest.org/web/files/public/unit6/core-competences/ BackgroundDocDefinitionsLegislationV10-FinalDraft.pdf. Accessed on 17 May 2010.
99. Franck WA, Bress NM, Singer FR, Krane SM. Rheumatic manifestations of Paget's disease of bone. Am J Med 1974 56: 592 603.
100. Kanis JA. Pathophysiology and Treatment of Paget's Disease of Bone.
101. Eekhoff ME, van der Klift M, Kroon HM, Cooper C, Hofman A, Pols HA et al. Paget's disease of bone in the Netherlands: a population-based radiological and biochemical survey-the Rotterdam Study. J Bone Miner Res 2004 19: 566 570.
102. Hocking LJ, Lucas GJ, Daroszewska A, Cundy T, Nicholson GC, Donath J et al. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res 2004 19: 1122 1127.